نتائج البحث

Quality of life and patient-reported toxicities in patients with advanced Merkel cell carcinoma treated with combined nivolumab and ipilimumab with or without stereotactic body radiation therapy.

• Authors : Hoogland AI; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.; Brohl AS

Subjects: Ipilimumab*/Ipilimumab*/Ipilimumab*/administration & dosage ; Ipilimumab*/Ipilimumab*/Ipilimumab*/adverse effects ; Ipilimumab*/Ipilimumab*/Ipilimumab*/therapeutic use

• Source: Cancer medicine [Cancer Med] 2024 Jul; Vol. 13 (14), pp. e7464.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial.

• Authors : Kato K; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.; Doki Y

Subjects: Ipilimumab*/Ipilimumab*/Ipilimumab*/administration & dosage ; Ipilimumab*/Ipilimumab*/Ipilimumab*/therapeutic use ; Ipilimumab*/Ipilimumab*/Ipilimumab*/adverse effects

• Source: Cancer medicine [Cancer Med] 2024 May; Vol. 13 (9), pp. e7235.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Cost-effectiveness of second-line ipilimumab for metastatic melanoma: A real-world population-based cohort study of resource utilization.

• Authors : Brandon Lu¹; Wei Fang Dai^2,3; Croxford, Ruth⁴

• Source: Cancer Medicine. May2023, Vol. 12 Issue 10, p11451-11461. 11p.

تفاصيل العنوان

Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma

• Authors : Kazuyuki Numakura; Yuya Sekine; Shingo Hatakeyama

Subjects: ipilimumab; lymph node metastasis; neoplasm metastasis

• Source: Cancer Medicine, Vol 12, Iss 16, Pp 16837-16845 (2023)

تفاصيل العنوان

Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma.

• Authors : Numakura, Kazuyuki¹ (AUTHOR) ; Sekine, Yuya¹ (AUTHOR); Hatakeyama, Shingo² (AUTHOR)

• Source: Cancer Medicine. Aug2023, Vol. 12 Issue 16, p16837-16845. 9p.

تفاصيل العنوان

Cost‐effectiveness of ipilimumab versus high‐dose interferon as an adjuvant therapy in resected high‐risk melanoma.

• Authors : Salans, Mia^1,2 (AUTHOR); Courtney, Patrick Travis^1,2 (AUTHOR); Yip, Anthony^1,2 (AUTHOR)

• Source: Cancer Medicine. Oct2021, Vol. 10 Issue 19, p6618-6626. 9p.

تفاصيل العنوان

Quality of life and patient‐reported toxicities in patients with advanced Merkel cell carcinoma treated with combined nivolumab and ipilimumab with or without stereotactic body radiation therapy

• Authors : Aasha I. Hoogland; Andrew S. Brohl; Brent J. Small

Subjects: immune checkpoint inhibitor therapy; Merkel cell carcinoma; patient‐reported outcomes

• Source: Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)

تفاصيل العنوان

Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29‐month follow‐up from a randomized, open‐label, phase III trial

• Authors : Ken Kato; Yuichiro Doki; Ian Chau

Subjects: cancer management; check point control; chemotherapy

• Source: Cancer Medicine, Vol 13, Iss 9, Pp n/a-n/a (2024)

تفاصيل العنوان

Salvage nivolumab and ipilimumab after prior anti‐PD‐1/PD‐L1 therapy in metastatic renal cell carcinoma: A meta‐analysis.

• Authors : Yang, Yuanquan¹ (AUTHOR); Mori, Sherry V.¹ (AUTHOR); Li, Mingjia¹ (AUTHOR)

• Source: Cancer Medicine. Apr2022, Vol. 11 Issue 7, p1669-1677. 9p.

تفاصيل العنوان

Real‐world survival of patients with advanced BRAF V600 mutated melanoma treated with front‐line BRAF/MEK inhibitors, anti‐PD‐1 antibodies, or nivolumab/ipilimumab.

• Authors : Moser, Justin C.¹ (AUTHOR) ; Chen, Danli² (AUTHOR); Hu‐Lieskovan, Siwen³ (AUTHOR)

• Source: Cancer Medicine. Dec2019, Vol. 8 Issue 18, p7637-7643. 7p.

تفاصيل العنوان